Didi Chuxing – “China’s Uber” – arrives for New York stockmarket listed
Chinese minicab company Didi Chuxing has filed for an initial public offering (IPO) in the US.
Chinese ride-hailing company Didi Chuxing has filed for an initial public offering (IPO) in the US, says Bloomberg. It was always expected to list at some stage, but the end of Covid-19 has prompted the company to accelerate its plans. It wants to raise some cash to help pay for its continued expansion and hopes to achieve a valuation of $70bn-$100bn.
At first glance, Didi’s hope of a $100bn valuation “does not seem too far-fetched”, says Lex in the Financial Times. It would value the company at around five times 2020 revenues, lower than the eight times Uber and Lyft command.
However, this is “misleading”, since Didi uses gross revenue figures, without deducting drivers’ salaries, which is how Uber and Lyft calculate their revenue. Adjusting Didi’s figures to take this into account means that the stock trades at 19 times sales. With ride-hailing still a “cut-throat” business in China, and “regulatory risks at home and abroad”, investors face having to “endure a steeper fare if they want to go along for the ride”. Still, Didi’s goal of at least a $70bn valuation is not unrealistic given that its IPO is “highly anticipated” and the IPO market is set to be “scorching hot” this summer, says Corrie Driebusch in the Wall Street Journal.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Fund managers, venture capitalists and bankers have said that sentiment around tech companies is “even crazier than during the dotcom boom of the late 1990s”. Indeed, with other companies, including investment platform Robinhood, also set to hit the markets next month, things are “busier than they have been in decades at this time of year”.
-
Polar Capital: a cheap, leveraged play on technologyPolar Capital has carved out a niche in fund management and is reaping the benefits
-
Vaccines inject billions into Big Pharma – how to profitThe vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Here's what it means for investors
-
Polar Capital: a cheap, leveraged play on technology
Polar Capital has carved out a niche in fund management and is reaping the benefits
-
Vaccines inject billions into Big Pharma – how to profit from the sector
The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Here's what it means for investors
-
'Investors should keep putting their trust in investment trusts'Interview Peter Walls, manager of the Unicorn Mastertrust fund, analyses investment trusts in a conversation with Andrew Van Sickle
-
Monks Investment Trust is worthy of the spotlightMonks Investment Trust, a global growth trust, sits in the shadow of its stablemate, Scottish Mortgage. But its record warrants attention, says Max King
-
New year, same market forecastsForecasts from banks and brokers are as bullish as ever this year, but there is less conviction about the US, says Cris Sholto Heaton
-
'Expect more policy U-turns from Keir Starmer'Opinion Keir Starmer’s government quickly changes its mind as soon as it runs into any opposition. It isn't hard to work out where the next U-turns will come from
-
Why does Donald Trump want Venezuela's oil?The US has seized control of Venezuelan oil. Why and to what end?
-
Britain heads for disaster – what can be done to fix our economy?Opinion The answers to Britain's woes are simple, but no one’s listening, says Max King
